Document is current
Any future updates will be listed below
-
Authors
Lim, Wee Shin
Chiu, Shu-I
Peng, Pei-Ling
Jang, Jyh-Shing Roger
Lee, Sol-Hee
Lin, Chin-Hsien
Kim, Han-Joon https://orcid.org/0000-0001-8219-9663
-
Funding
Funding for this research was provided by:
National Science and Technology Council (112-2221-E-002 -188 -MY3)
Korea Health Industry Development Institute (RS-2023-00265517)
Seoul National University Hospital
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 17 December 2024
First Online: 30 December 2024
Declarations
:
: HJK received research grants from Seoul National University Hospital, National Information Society Agency, Ministry of Science and ICT, Ministry of Health and Welfare, Samil Pharmaceutical, Emocog, GemVax & KAEL, and Bukwang Pharm Co Ltd; travel grant from International Parkinson and Movement Disorder Society. JH Shin received research grants support from National Research Foundation of Korea, Seoul National University Hospital and Seoul National University College of Medicine, Received travel grant from Movement disorder Society and Global Parkinson project. CHL received research grants from National Taiwan University Hospital and National Science and Technology Council. JSR Jang received grants from National Taiwan University and National Science and Technology Council. Other authors have nothing to disclose. The authors report no competing interests related to this study.
: This research was carried out in accordance with the principles outlined in the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Seoul National University Hospital (IRB number: 2211–079-1378) and National Taiwan University Hospital (201912112RIND). Since this study was retrospective in nature, written consent from the patients was waived. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
